75 related articles for article (PubMed ID: 3121488)
1. Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure.
Barbarino A; De Marinis L; Mancini A; D'Amico C; Sambo P; Passeri M; Anile C; Maira G
Horm Res; 1987; 27(3):141-51. PubMed ID: 3121488
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid pressure and prolactin in empty sella syndrome.
Maira G; Anile C; De Marinis L; Mancini A; Barbarino A
Can J Neurol Sci; 1990 Feb; 17(1):92-4. PubMed ID: 2107018
[TBL] [Abstract][Full Text] [Related]
3. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
Celani MF; Giambuzzi G; Simoni M; Montanini V
J Endocrinol Invest; 1987 Aug; 10(4):421-5. PubMed ID: 3119699
[TBL] [Abstract][Full Text] [Related]
4. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
5. Relationships between intracranial pressure and diurnal prolactin secretion in primary empty sella.
Maira G; Anile C; Cioni B; Menini E; Mancini A; De Marinis L; Barbarino A
Neuroendocrinology; 1984 Feb; 38(2):102-7. PubMed ID: 6425707
[TBL] [Abstract][Full Text] [Related]
6. Opioid-dopaminergic interactions in primary empty sella.
Mancini A; Conte G; Fiumara C; Fabrizi ML; Iacona T; Zuppi P; Colosimo C; De Marinis L
Exp Clin Endocrinol; 1993; 101(5):277-82. PubMed ID: 8299703
[TBL] [Abstract][Full Text] [Related]
7. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Brismar K
Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
[TBL] [Abstract][Full Text] [Related]
8. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
[TBL] [Abstract][Full Text] [Related]
9. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
Timmerman W; Poelman RT; Westerink BH; Schuiling GA
Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
[TBL] [Abstract][Full Text] [Related]
10. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms.
Kapcala LP; Molitch ME; Arno J; King LW; Reichlin S; Wolpert SM
J Endocrinol Invest; 1984 Oct; 7(5):455-60. PubMed ID: 6439770
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of serum prolactin response to sequential thyrotropin-releasing hormone and chlorpromazine stimulation in patients with primary empty sella syndrome.
Futterweit W; Smith H; Holt JE
Fertil Steril; 1984 Oct; 42(4):573-8. PubMed ID: 6436062
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
14. Galanin positively modulates prolactin secretion in normal women.
Grottoli S; Arvat E; Gianotti L; Ramunni J; Di Vito L; Maccagno B; Ciccarelli E; Camanni F; Ghigo E
J Endocrinol Invest; 1996 Dec; 19(11):739-44. PubMed ID: 9061507
[TBL] [Abstract][Full Text] [Related]
15. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
[TBL] [Abstract][Full Text] [Related]
16. Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Barbarino A; De Marinis L; Mancini A; Menini E; D'Amico C; Passeri M; Sambo P; Anile C; Maira G
Acta Endocrinol (Copenh); 1985 Sep; 110(1):10-6. PubMed ID: 3929517
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
18. The exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide in 1,2-dibromo-3-chloropropane-induced azoospermia.
Leroith D; Potashnik G; Dunn J; Spitz IM
J Clin Endocrinol Metab; 1981 Jan; 52(1):38-41. PubMed ID: 6778892
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism.
Röjdmark S; Adner N; Andersson DE; Austern J; Lamminpää K
J Clin Endocrinol Metab; 1984 Oct; 59(4):595-600. PubMed ID: 6434573
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
